Literature DB >> 3699813

Histologic parathyroid abnormalities in an autopsy series.

G Akerström, C Rudberg, L Grimelius, R Bergström, H Johansson, S Ljunghall, J Rastad.   

Abstract

The parathyroid glands from 422 subjects without clinical, biochemical, or advanced histologic signs of renal disease were dissected at autopsy. The glands were evaluated histologically in relation to the subjects' age, sex, histologic renal features, other diseases, and medical therapy. Normal parathyroid glands generally had diffuse cellular arrangements, with variable fat cell content. Increased nodularity was observed, especially in enlarged parathyroid glands. Hyperplasia was present in 7 per cent and adenomas in 2.4 per cent. Hyperplastic glands were often nodular and asymmetric, and numbers of oxyphil cells were frequently increased. Some large nodules were histologically indistinguishable from adenomas. Serum calcium levels were elevated in subjects with adenomas or with hyperplastic glands containing large nodules. The findings seem to indicate that nodularity of the parathyroid tissue is a sign of abnormality and that adenomas may arise from such nodular hyperplasia. Hyperplasia and adenomas were more common in elderly subjects and in those with slight or moderate nephrosclerosis. Other diseases or medical therapy were not found to be correlated with parathyroid weight or histologic features.

Entities:  

Mesh:

Year:  1986        PMID: 3699813     DOI: 10.1016/s0046-8177(86)80043-0

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  22 in total

1.  Causes of failed primary exploration and technical aspects of re-operation in primary hyperparathyroidism.

Authors:  G Akerström; C Rudberg; L Grimelius; H Johansson; B Lundström; J Rastad
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

Review 2.  Cellular physiology and pathophysiology of the parathyroid glands.

Authors:  G Akerström; J Rastad; S Ljunghall; P Ridefelt; C Juhlin; E Gylfe
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

3.  Indian primary hyperparathyroidism patients with parathyroid carcinoma do not differ in clinicoinvestigative characteristics from those with benign parathyroid pathology.

Authors:  Gaurav Agarwal; Kaushal K Prasad; Dilip K Kar; Narendra Krishnani; Rakesh Pandey; Saroj K Mishra
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

4.  Parathyroid histology and cytology with monoclonal antibodies recognizing a calcium sensor of parathyroid cells.

Authors:  C Juhlin; J Rastad; L Klareskog; L Grimelius; G Akerström
Journal:  Am J Pathol       Date:  1989-08       Impact factor: 4.307

5.  Secretory disturbance in hyperplastic parathyroid nodules of uremic hyperparathyroidism: implication for parathyroid autotransplantation.

Authors:  C H Wallfelt; R Larsson; E Gylfe; S Ljunghall; J Rastad; G Akerström
Journal:  World J Surg       Date:  1988-08       Impact factor: 3.352

Review 6.  Endocrine incidentalomas--challenges imposed by incidentally discovered lesions.

Authors:  Dimitra A Vassiliadi; Stylianos Tsagarakis
Journal:  Nat Rev Endocrinol       Date:  2011-06-28       Impact factor: 43.330

7.  Parathyroid incidentaloma.

Authors:  Seema Khanna; Seema Singh; Ajay K Khanna
Journal:  Indian J Surg Oncol       Date:  2012-03-28

8.  Role of parathyroid hormone in mediating age-related changes in bone resorption in men.

Authors:  Kurt A Kennel; B Lawrence Riggs; Sara J Achenbach; Ann L Oberg; Sundeep Khosla
Journal:  Osteoporos Int       Date:  2003-07-08       Impact factor: 4.507

9.  Primary hyperparathyroidism: epidemiology, diagnosis and clinical picture.

Authors:  S Ljunghall; P Hellman; J Rastad; G Akerström
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

Review 10.  The role of the pathologist in diagnosis and surgical decision making in hyperparathyroidism.

Authors:  L Grimelius; G Akerström; L Bondeson; C Juhlin; H Johansson; S Ljunghall; J Rastad
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.